• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖症:生活方式管理、减肥手术、药物以及肠道激素的治疗性应用。

Obesity: Lifestyle management, bariatric surgery, drugs, and the therapeutic exploitation of gut hormones.

作者信息

Behary Preeshila, Cegla Jaimini, Tan Tricia M, Bloom Stephen R

机构信息

Division of Diabetes, Endocrinology and Metabolism, Hammersmith Hospital, Imperial College London , Du Cane Road, London , UK.

出版信息

Postgrad Med. 2015 Jun;127(5):494-502. doi: 10.1080/00325481.2015.1048181.

DOI:10.1080/00325481.2015.1048181
PMID:26040552
Abstract

Obesity is on the rise and the pursuit of efficient and safe treatment is ongoing. Available anti-obesity medical therapies have so far proved to be disappointing, whereas bariatric surgery is leading the way and offers long-term health benefits. Part of the success of bariatric surgery is thought to be mediated by gut hormones. A better understanding of the role of gut hormones within the gut-brain signaling pathway in the control of hunger, satiety, and energy homeostasis, has led to their therapeutic exploitation as possible anti-obesity drugs. In this review, we provide a summary of currently available treatment options for obesity from simple lifestyle modifications and bariatric surgery to traditional and novel medical therapies.

摘要

肥胖率正在上升,人们仍在不断寻求高效且安全的治疗方法。到目前为止,现有的抗肥胖药物疗法都令人失望,而减肥手术却引领潮流并带来长期健康益处。减肥手术的部分成功被认为是由肠道激素介导的。对肠道激素在肠道-大脑信号通路中控制饥饿、饱腹感和能量平衡方面作用的更好理解,促使人们将其作为可能的抗肥胖药物进行治疗性开发。在本综述中,我们总结了目前可用的肥胖治疗方案,从简单的生活方式改变、减肥手术到传统和新型药物疗法。

相似文献

1
Obesity: Lifestyle management, bariatric surgery, drugs, and the therapeutic exploitation of gut hormones.肥胖症:生活方式管理、减肥手术、药物以及肠道激素的治疗性应用。
Postgrad Med. 2015 Jun;127(5):494-502. doi: 10.1080/00325481.2015.1048181.
2
A new era in gut hormone-based pharmacotherapy for people with obesity.基于肠道激素的肥胖症药物治疗新时代。
Proc Nutr Soc. 2022 Sep;81(3):217-226. doi: 10.1017/S0029665122002695. Epub 2022 Sep 7.
3
Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.体重减轻与生活方式治疗、药物治疗和减重手术预防和治疗 2 型糖尿病:作用机制。
Curr Obes Rep. 2015 Jun;4(2):287-302. doi: 10.1007/s13679-015-0155-x.
4
Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery?肠道激素模拟药物或其受体靶向药物最终会取代减重手术吗?
Metabolism. 2019 Nov;100:153960. doi: 10.1016/j.metabol.2019.153960. Epub 2019 Aug 11.
5
Obesity, gut hormones, and bariatric surgery.肥胖、肠道激素与减肥手术
World J Surg. 2009 Oct;33(10):1983-8. doi: 10.1007/s00268-009-0080-9.
6
Changes in gut hormones after bariatric surgery.减肥手术后肠道激素的变化。
Clin Endocrinol (Oxf). 2008 Aug;69(2):173-9. doi: 10.1111/j.1365-2265.2007.03164.x. Epub 2007 Dec 20.
7
Treating obesity: is it all in the gut?治疗肥胖症:问题全出在肠道吗?
Drug Discov Today. 2014 Jul;19(7):845-58. doi: 10.1016/j.drudis.2013.10.025. Epub 2013 Nov 27.
8
Hormonal Gut-Brain Signaling for the Treatment of Obesity.激素肠道-大脑信号在肥胖治疗中的作用。
Int J Mol Sci. 2023 Feb 8;24(4):3384. doi: 10.3390/ijms24043384.
9
Treating the Chronic Disease of Obesity.治疗肥胖这一慢性疾病。
Med Clin North Am. 2021 Nov;105(6):983-1016. doi: 10.1016/j.mcna.2021.06.005.
10
Can Bayliss and Starling gut hormones cure a worldwide pandemic?贝利斯和斯塔林肠道激素能治愈全球大流行疾病吗?
J Physiol. 2014 Dec 1;592(23):5153-67. doi: 10.1113/jphysiol.2014.272955. Epub 2014 Sep 12.

引用本文的文献

1
A New Strategy for Obesity Treatment: Revealing the Frontiers of Anti-obesity Medications.肥胖治疗的新策略:揭示抗肥胖药物的前沿领域。
Curr Mol Med. 2025;25(1):13-26. doi: 10.2174/0115665240270426231123155924.
2
Impact of Bariatric Surgery on Sexual Dysfunction in Obese Men.减肥手术对肥胖男性性功能障碍的影响。
Sex Med. 2021 Apr;9(2):100322. doi: 10.1016/j.esxm.2021.100322. Epub 2021 Feb 13.
3
Canola oil rich in oleic acid improves diastolic heart function in diet-induced obese rats.富含油酸的菜籽油可改善饮食诱导肥胖大鼠的舒张期心脏功能。
J Physiol Sci. 2017 May;67(3):425-430. doi: 10.1007/s12576-016-0504-x. Epub 2016 Dec 1.
4
How do patients' clinical phenotype and the physiological mechanisms of the operations impact the choice of bariatric procedure?患者的临床表型和手术的生理机制如何影响减肥手术的选择?
Clin Exp Gastroenterol. 2016 Jul 22;9:181-9. doi: 10.2147/CEG.S87205. eCollection 2016.
5
Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives.盐酸纳曲酮/盐酸安非他酮用于肥胖成年人的慢性体重管理:患者选择与观点
Patient Prefer Adherence. 2016 May 4;10:751-9. doi: 10.2147/PPA.S84778. eCollection 2016.
6
Post-prandial anorexigenic gut peptide, appetite and glucometabolic responses at different eating rates in obese patients undergoing laparoscopic sleeve gastrectomy.接受腹腔镜袖状胃切除术的肥胖患者在不同进食速率下的餐后厌食性肠肽、食欲及糖代谢反应
Endocrine. 2017 Jan;55(1):113-123. doi: 10.1007/s12020-016-0933-6. Epub 2016 Mar 29.
7
Unmet Needs in the Treatment of Gastroesophageal Reflux Disease.胃食管反流病治疗中未满足的需求
J Neurogastroenterol Motil. 2015 Jul 30;21(3):309-19. doi: 10.5056/jnm15105.